Crossref
Novel antipsychotic shows efficacy in Phase 2 schizophrenia trial
The Brown University Psychopharmacology Update · 2026-08 · 37 (8) · 6-7
DOI: 10.1002/pu.31476 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Brown University Psychopharmacology Update, online erschienen am 28.06.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Novel antipsychotic shows efficacy in Phase 2 schizophrenia trial. The Brown University Psychopharmacology Update, 37(8), 6-7. https://doi.org/10.1002/pu.31476
Vancouver
Novel antipsychotic shows efficacy in Phase 2 schizophrenia trial. The Brown University Psychopharmacology Update. 2026;37(8):6-7. doi:10.1002/pu.31476
BibTeX
@article{euvimed2026,
title = {Novel antipsychotic shows efficacy in Phase 2 schizophrenia trial},
journal = {The Brown University Psychopharmacology Update},
year = {2026},
volume = {37},
number = {8},
pages = {6--7},
doi = {10.1002/pu.31476}
}
EUVIMED